First-line Gemcitabine <i>Versus</i> Treatment of Physician's Choice for Metastatic Breast Cancer: A Prospective Cohort Study.

导出原文传递

翻译打印收藏纠错

第一作者： Shinya,Yamamoto

第一单位： Yokohama City University Medical Center, Department of Breast and Thyroid Surgery, Yokohama, Japan.

作者： Shinya,Yamamoto ^[1] ; Kazutaka,Narui ^[2] ; Takashi,Ishikawa ^[1] ; Shoko,Adachi ^[1] ; Kazuhiro,Shimada ^[1] ; Daisuke,Shimizu ^[1] ; Akimitsu,Yamada ^[3] ; Sadatoshi,Sugae ^[3] ; Mikiko,Tanabe ^[4] ; Mari,Oba ^[5] ; Satoshi,Morita ^[6] ; Takako,Doi ^[7] ; Satoshi,Hasegawa ^[8] ; Tomoyuki,Morita ^[9] ; Ayako,Kito ^[10] ; Takashi,Chishima ^[11] ; Yasushi,Ichikawa ^[12] ; Itaru,Endo ^[3] ; YOKOHAMA CLINCAL ONCOLOGY GROUP

作者单位： Yokohama City University Medical Center, Department of Breast and Thyroid Surgery, Yokohama, Japan. ^[1] Yokohama City University Medical Center, Department of Breast and Thyroid Surgery, Yokohama, Japan; nr1@gc5.so-net.ne.jp. ^[2] Yokohama City University Graduate School of Medicine, Department of Gastroenterological Surgery, Yokohama, Japan. ^[3] Yokohama City University Medical Center, Department of Pathology, Yokohama, Japan. ^[4] Yokohama City University Medical Center, Department of Biostatics and Epidemiology, Yokohama, Japan. ^[5] Kyoto University Graduate School of Medicine, Department of Biomedical Statistics and Bioinformatics, Kyoto, Japan. ^[6] Shonan Kinen Hospital, Breast Center, Kamakura, Japan. ^[7] Saiseikai Yokohama-shi Nanbu Hospital, Department of Surgery, Yokohama, Japan. ^[8] Yokosuka Kyosai Hospital, Department of Surgery, Yokosuka, Japan. ^[9] Yokohama Municipal Citizen's Hospital, Department of Breast Surgery, Yokohama, Japan. ^[10] Yokohama Rosai Hospital, Department of Breast Surgery, Yokohama, Japan. ^[11] Yokohama City University Graduate School of Medicine, Department of Clinical Oncology, Yokohama, Japan. ^[12]

关键词 Metastatic breast cancer gemcitabine treatment of physician’s choice